The navigation below allows you to jump to any table or figure within the SEER Cancer Statistics Review.

  1. First select the CSR Section, then a Table/Figure from that section.
  2. Use the Submit button to view the table or figure. You will have options to download a printer-friendly version (PDF) or the data table (CSV) as well.

To learn more about the Cancer Statistics Review and the statistics presented in this report, refer to the About the CSR (PDF, 524 KB) and Technical Notes (PDF, 756 KB) pages.


Download and Print: Download Printer-friendly PDF Download data

Table 2.21

All Cancer Sites (Invasive)

United States Cancer Prevalence Estimates

Estimated United States Cancer Prevalence Counts a on January 1, 2013
By Race/Ethnicity, Sex and Years Since Diagnosis
Race/Ethnicity Sex Years Since Diagnosis Completeh
0 to <5 5 to <10 10 to <15 15 to <20 20 to <25 25 to <30 0 to <21e 0 to <38e >=38g
All Races b Both Sexes 4,683,633 3,302,218 2,388,027 1,512,405 914,197 534,563 12,499,657 13,793,147 347,107 14,140,254
Males 2,371,817 1,687,487 1,160,300 679,900 350,628 174,108 6,148,336 6,558,326 71,818 6,630,144
Females 2,311,816 1,614,731 1,227,727 832,505 563,569 360,455 6,351,321 7,234,821 275,289 7,510,110
White b Both Sexes 3,918,402 2,837,504 2,087,003 1,335,669 824,524 485,175 10,730,652 11,904,805 302,738 12,207,543
Males 1,978,263 1,442,623 1,007,901 598,480 319,935 159,759 5,253,660 5,630,885 67,228 5,698,113
Females 1,940,139 1,394,881 1,079,102 737,189 504,589 325,416 5,476,992 6,273,920 235,510 6,509,430
Black b Both Sexes 496,816 308,718 202,127 116,659 57,326 30,618 1,163,805 1,238,540 21,389 1,259,929
Males 262,272 169,178 109,086 57,293 20,443 8,443 612,963 632,563 1,749 634,312
Females 234,544 139,540 93,041 59,366 36,883 22,175 550,842 605,977 19,640 625,617
Asian/
Pacific
Islander c		 Both Sexes 152,791 96,072 63,136 + + + 354,019 + + +
Males 63,892 39,982 24,230 + + + 142,568 + + +
Females 88,899 56,090 38,906 + + + 211,451 + + +
Hispanic d Both Sexes 340,558 215,426 141,713 + + + 793,696 + + +
Males 159,609 101,176 63,795 + + + 363,689 + + +
Females 180,949 114,250 77,918 + + + 430,007 + + +
Estimated prevalence percent a on January 1, 2013, of the SEERc population diagnosed in the previous 21 years
By Age at Prevalence, Race/Ethnicity and Sex
Race/Ethnicity Sex Age Specific (Crude) Age-Adjustedf
All Ages 0-9 10-19 20-29 30-39 40-49 50-59 60-69 70-79 80+ All Ages
All Races c Both Sexes 3.4482% 0.0866% 0.1883% 0.3439% 0.7993% 1.9479% 4.4448% 9.5130% 16.2143% 18.3787% 3.2687%
Males 3.4122% 0.0900% 0.1984% 0.3357% 0.6326% 1.3471% 3.5996% 10.0279% 20.4610% 26.0822% 3.6128%
Females 3.4833% 0.0830% 0.1777% 0.3525% 0.9668% 2.5434% 5.2551% 9.0480% 12.7542% 13.7760% 3.0751%
White c Both Sexes 3.8037% 0.0938% 0.2073% 0.3904% 0.8983% 2.0934% 4.6502% 9.9348% 17.1170% 19.1670% 3.4481%
Males 3.7336% 0.0966% 0.2203% 0.3830% 0.7191% 1.4735% 3.7359% 10.2671% 21.1825% 26.6695% 3.7488%
Females 3.8735% 0.0910% 0.1936% 0.3982% 1.0869% 2.7343% 5.5560% 9.6241% 13.7170% 14.6278% 3.2916%
Black c Both Sexes 2.6037% 0.0659% 0.1323% 0.2221% 0.5426% 1.5976% 4.2293% 9.9567% 16.2183% 16.3911% 3.1028%
Males 2.8675% 0.0683% 0.1304% 0.2199% 0.3999% 1.1222% 4.0876% 12.8552% 24.2461% 27.8880% 4.0796%
Females 2.3635% 0.0634% 0.1343% 0.2243% 0.6678% 2.0155% 4.3528% 7.6916% 10.6142% 10.7379% 2.5029%
Asian/
Pacific
Islander c		 Both Sexes 2.1998% 0.0665% 0.1395% 0.2080% 0.4921% 1.3929% 3.1810% 6.0037% 9.8741% 12.8225% 2.1496%
Males 1.8903% 0.0731% 0.1446% 0.1907% 0.3314% 0.7223% 1.9710% 5.2688% 11.4823% 17.8667% 2.1040%
Females 2.4836% 0.0595% 0.1342% 0.2256% 0.6373% 1.9859% 4.2231% 6.6081% 8.6238% 9.7323% 2.2421%
Hispanic d Both Sexes 1.5228% 0.0812% 0.1766% 0.2786% 0.5914% 1.3797% 3.1675% 6.7103% 11.6348% 13.7425% 2.3775%
Males 1.3722% 0.0850% 0.1866% 0.2807% 0.4606% 0.8730% 2.2715% 6.6874% 15.1864% 20.3684% 2.6257%
Females 1.6761% 0.0774% 0.1662% 0.2763% 0.7304% 1.9070% 4.0297% 6.7300% 9.0024% 9.7529% 2.2775%

Footnotes:

a US 2013 cancer prevalence counts are based on 2013 cancer prevalence proportions from the SEER registries and 1/1/2013 US population estimates based on the average of 2012 and 2013 population estimates from the US Bureau of the Census. Prevalence was calculated using the First Malignant Primary Only for a person.

b Statistics based on SEER 9 Areas.

c Statistics based on SEER 13 Areas excluding the Alaska Native Registry

d Statistics based on NHIA for Hispanic for SEER 13 Areas excluding the Alaska Native Registry.

e Maximum limited-duration prevalence: 38 years for 1975-2013 SEER 9 data; 21 years for 1992-2013 SEER 13 data (excluding the Alaska Navtive Registry) used to calculate prevalence for Hispanics and Asian Pacific Islanders.

f Percentages are age-adjusted to the 2000 US Standard Population (19 age groups - Census P25-1130) by 5-year age groups.

g Cases diagnosed more than 38 years ago were estimated using the completeness index method (Capocaccia et. al. 1997, Merrill et. al. 2000).

h Complete prevalence is obtained by summing 0 to <38 and >=38.

i Age-specific completeness index was approximated using empirical data from historical Connecticut tumor registry.

- Statistic not shown. Statistic based on fewer than 5 cases estimated alive in SEER for the time interval.

+ Not available.

Page Navigation: << Previous Next >>

The information on this page is archived and provided for reference purposes only. Persons with disabilities having difficulty accessing information on this page may e-mail for assistance.